🇺🇸 FDA
Pipeline program

Vonoprazan

PJKT2024-109

Approved small_molecule active

Quick answer

Vonoprazan for Ulcers, Gastric is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Ulcers, Gastric
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials